26th week of 2011 patent applcation highlights part 44 |
Patent application number | Title | Published |
20110158852 | OFFSET PATH MIXERS AND FLUID SYSTEMS INCLUDNG THE SAME - Static mixers and fluid systems incorporating one or more of the static mixers. The static mixers include one or more channels that provide a fluid path through a body, wherein fluid flowing through each channel defines a downstream direction through the channel. The channel includes two or more sets of concatenated mixing elements arranged adjacent to each other across the width of the channel, wherein two sets of the mixing elements are offset from each other along the downstream direction of the channel. | 2011-06-30 |
20110158853 | PIXEL-TYPE BIOLOGICAL ANALYSIS DEVICE, BIOSENSOR, AND FABRICATION PROCESSES THEREOF - The disclosure relates to a pixel-type biological analysis device comprising a photosensitive layer, a capture mixture for the capture of targeted proteins, the capture mixture being placed on an external surface of the photosensitive layer and comprising a protein probe grafted to a hydrogel, collection means for collecting photoelectrons in the photosensitive layer, and reading and treatment means of an electrical quantity supplied by the collection means, for the supply of a characteristic value of a luminous intensity detected by the photosensitive layer. | 2011-06-30 |
20110158854 | HYDROGEN CONCENTRATION MEASURING INSTRUMENT - This invention is to obtain a highly reliable measurement result by correcting a hydrogen concentration by the use of a concentration of oxygen contained in a measurement gas, and the hydrogen concentration measuring instrument comprises a hydrogen concentration measuring part | 2011-06-30 |
20110158855 | Concentration of Particles in a Fluid Within an Acoustic Standing Wave Field - A device for performing the manipulation of particles suspended in a fluid is disclosed. The device comprises a duct for the flow of a fluid in which particles are suspended, an acoustic transducer, and a reflector for establishing an acoustic standing wave field across the width of the duct. It has been unexpectedly found that optimum performance of the device occurs when the spacing between the transducer and a reflector is 300 microns or less. The device seeks to overcome prior engineering difficulties that prevented one from observing the individual particle bands or separating the individual particle bands from the duct. | 2011-06-30 |
20110158856 | PROCESS FOR PRODUCTION OF AMPHOTERIC ELECTROLYTE RESIN BY CONTINUOUS BULK POLYMERIZATION AND APPARATUS FOR THE PRODUCTION - A continuous polymerization apparatus is provided for producing an amphoteric electrolyte resin by continuous bulk polymerization at low cost, which apparatus includes a reaction vessel, the reaction vessel including at least four polymerization zones adjacent to each other in series, each polymerization zone being separated by a partition plate, the partition plates admitting a stirring shaft with stirrers, each of the polymerization zones having a thermosensor for sensing temperature within the polymerization zone, a heating device for heating the polymerization zone and a cooling device for cooling the polymerization zone. | 2011-06-30 |
20110158857 | FLUIDIZED BED REACTOR SYSTEMS AND DISTRIBUTORS FOR USE IN SAME - Fluidized bed reactor systems and distributors are disclosed as well as processes for producing polycrystalline silicon from a thermally decomposable silicon compound such as trichlorosilane. The processes generally involve reduction of silicon deposits on reactor walls during polycrystalline silicon production by use of a silicon tetrahalide. | 2011-06-30 |
20110158858 | WASTE TO LIQUID HYDROCARBON REFINERY SYSTEM - A Waste to Liquid Hydrocarbon Refinery System that transforms any municipal solid wastes and hazardous industrial wastes, Biomass or any carbon containing feedstock into synthetic hydrocarbon, particularly, but not exclusively, diesel and gasoline and/or electricity and co-generated heat, comprising three major subsystems: i) the Pyro-Electric Thermal Converter (PETC) ( | 2011-06-30 |
20110158859 | PROCESS FOR ISOMERIZING A NON-EQUILIBRIUM ALKYLAROMATIC FEED MIXTURE AND AN AROMATIC PRODUCTION FACILITY - One exemplary embodiment can be a process for the isomerization of a non-equilibrium alkylaromatic feed mixture. The process can include contacting the non-equilibrium alkylaromatic feed mixture in a C8 isomerization zone. The C8 isomerization zone may include a first isomerization stage and a second isomerization stage. At the first isomerization stage, at least a portion of the non-equilibrium alkylaromatic feed mixture can be contacted at a first isomerization condition in a liquid phase in the substantial absence of hydrogen to obtain an intermediate stream. At the second isomerization stage, at least part of the intermediate stream and at least a part of a stream rich in at least one naphthene can be contacted at a second isomerization condition to obtain a concentration of at least one alkylaromatic isomer that is higher than a concentration of that at least one alkylaromatic isomer in the non-equilibrium feed mixture. | 2011-06-30 |
20110158860 | FUEL REFORMER - A fuel reformer is provided that is capable of improving endurance and performance. The fuel reformer includes a first burner having a first-burner first end, a first-burner second end, and a first opening formed in the first-burner first end; a second burner surrounding the first burner and having a second-burner second end, a second-burner second end, and a second opening in the second-burner first end, wherein the second-burner second end is coupled to the first-burner second end to communicate a fluid. The reforming reactor is configured to generate heat from the first and second burners, and has a fuel supply including a nozzle unit in the first burner and supplies a second oxidation fuel from the outside to the first burner. A first oxidation fuel is introduced into the first opening and flows through the first burner in a first direction and flows through the second burner in a third direction opposite to the first direction. The nozzle unit discharges the second oxidation fuel in a second direction crossing the first direction. | 2011-06-30 |
20110158861 | VOLATILITY-TYPE ISOLATION AND PURIFICATION DEVICE - The present invention discloses a volatility-type isolation and purification device comprising a substrate and at least one separation region. The surface of the at least one separation region comprises at least one immobilization layer. When a mixture solution comprising at least one substance to be separated is dropped on the at least one separation region, the substances to be separated each is immobilized on the immobilization layer respectively by the volatility or hysteresis of the mixture solution itself. | 2011-06-30 |
20110158862 | ESCALATOR HANDRAIL STERILIZER - The present invention is an escalator handrail sterilizer which is installed close to an inlet or outlet of an escalator handrail, and cleans and sterilizes the handrail moving in or out. The sterilizer comprises a case which is prepared for surrounding the escalator handrail, a chemical spray unit which is prepared in one end inside the case to spray chemicals on the handrail moving in, an ultraviolet ray irradiation unit which is prepared in the other end inside the case to project ultraviolet rays on the chemical-sprayed handrail, a drying unit which dries the chemicals sprayed on the handrail, a control unit which controls the chemical spray unit, the UV irradiation unit and the drying unit, and a cover which is prepared in both ends of the case in order to prevent foreign materials from flowing into the case. | 2011-06-30 |
20110158863 | HOLDING MATERIAL FOR CATALYTIC CONVERTER - The present invention relates to a holding material for a catalytic converter containing a catalyst carrier, a metal casing for receiving the catalyst carrier, and the holding material wound around the catalyst carrier and interposed in a gap between the catalyst carrier and the metal casing, in which the holding material contains an organic substrate and a protective film having a plurality of pores, and the protective film is joined to a metal casing-side surface of the substrate. | 2011-06-30 |
20110158864 | Physiological Test Device - The present invention discloses a physiological test device, which is used to test multiple physiological parameters in vitro and able to indicate the current test item with lights, sounds, images, text or a combination thereof lest the user be confused by the multiple functions of the test device or different test results thereof. The present invention can prevent the user from mistaking the test type or test result, and thus can overcome the conventional problems that the multiple functions of a single test device confuse the user. Thus, the user will not take a wrong test piece or obtain a wrong test result. | 2011-06-30 |
20110158865 | Reagent Cabinet System - A reagent cabinet for an automated processing apparatus. The reagent cabinet has a housing, and a drawer slidably mounted in the housing. The drawer has a lower deck adapted to receive a fluid reservoir, and an upper deck located above the lower deck and adapted to receive a fluid supply container. A supply connection hose is provided to selectively connect the fluid supply container to the fluid reservoir. A reservoir connection hose is provided to selectively connect to the fluid reservoir and to convey fluid from the fluid reservoir to a downstream location outside the cabinet. A pump is mounted on the drawer. The pump is adapted to convey fluid through either the supply connection hose or the reservoir connection hose. | 2011-06-30 |
20110158866 | REFORMER WITH HIGH DURABILITY - A reformer including a heating unit, a first combustor for receiving and oxidizing a heating unit fuel at a first end of the heating unit, and a second combustor for receiving and oxidizing an anode off gas at a second end of the heating unit, a reforming unit having a first reforming portion surrounding the heating unit, a second reforming portion surrounding the first reforming portion, and a flow path portion connecting the first reforming portion and the second reforming portion to provide fluid communication therebetween, and a heat resistant shield between the flow path portion and the second combustor. Here, the heat resistant shield protects the reforming unit from being distorted by thermal expansion caused by the heating unit. In addition, the flow path portion may be formed with a blade configured to further protect the connector from being distorted by thermal expansion. | 2011-06-30 |
20110158867 | REFORMER WITH HIGH DURABILITY - A reformer having high durability and including a heating unit and a reforming unit. The heating unit has a hollow cylindrical shape or polygonal shape and a first combustor and a second combustor that receives and oxidizes heating unit fuel and anode off gas (AOG) at both ends thereof. The reforming unit includes a first reforming portion formed to surround the exterior of the heating unit, a second reforming portion formed to surround the exterior of the first reforming portion and a flow path portion connecting the first reforming portion and the second reforming portion to provide fluid communication therebetween. The flow path portion includes a pre-deformed portion extending along a direction substantially perpendicular to the central axis of the heating unit. | 2011-06-30 |
20110158868 | IMPROVEMENT TO THE BAYER PROCESS FOR PRODUCING ALUMINA TRIHYDRATE, SAID PROCESS COMPRISING A STEP IN WHICH THE SUPERSATURATED LIQUOR IS FILTERED AT HIGH TEMPERATURE BEFORE DECOMPOSITION - Process for manufacturing alumina trihydrate by alkaline attack of bauxite, following the general steps of the Bayer process, and during which, after settling and before decomposition, the aluminate liquor undergoes a filtration, known as security filtration, so that at the end of the filtration it contains less than 10 mg/l of insoluble particles, characterized in that, during said security filtration, a filtration device is used that comprises a zone in which the liquor is subjected, after passing through said filtration media, to a pressure greater than 2 bar, preferably greater than 3 bar. Preferably, this device also comprises a zone in which the liquor is subjected, before passing through the filtration media, to a pressure greater than 5 bar, preferably greater than 6, typically in the vicinity of 7 bar. In this way, the aluminate liquor can be kept at a high temperature during the security filtration, typically greater than 130° C., preferably greater than 140° C., and be brought to a high degree of supersaturation Rp, typically greater than 1.25, without risk of reversion. | 2011-06-30 |
20110158869 | PROCESSING METHOD FOR RECOVERING IRON OXIDE AND HYDROCHLORIC ACID - A method of processing waste iron chloride solution including ferrous chloride, ferric chloride or mixtures thereof and optionally free hydrochloric acid, includes concentrating waste iron chloride solution into concentrated liquid having iron chloride concentration of at least 30%-40% by weight; optionally oxidizing ferrous chloride in the concentrated liquid from the concentration step to ferric chloride providing liquid containing ferric chloride; hydrolyzing the liquid containing ferric chloride from the oxidation step at 155-350° C., maintaining the ferric chloride concentration at least at 65% by weight, generating steam containing hydrogen chloride and liquid containing ferric oxide; separating ferric oxide from the liquid containing ferric oxide in the hydrolysis step; condensing steam containing hydrogen chloride in the hydrolysis step, recovering hydrochloric acid at a concentration of at least 10%-15% by weight; and using condensation energy of the hydrogen chloride containing steam in the recovery step to heat the concentration step performed under reduced pressure. | 2011-06-30 |
20110158870 | METHOD FOR OPERATING A DEVICE HAVING AT LEAST ONE ELECTRICALLY HEATABLE HONEYCOMB BODY AND DEVICE FOR THE CATALYTIC CONVERSION OF EXHAUST GASES - A method is provided for operating a device having at least one electrically heatable honeycomb body through which an exhaust gas can flow. The electrically heatable honeycomb body has at least one current distribution structure to which a plurality of short, successive voltage pulses are initially applied during activation, before a constant heating voltage is applied to the current distribution structure to heat the honeycomb body. A suitable device for the catalytic conversion of exhaust gases in an exhaust system is also provided. | 2011-06-30 |
20110158871 | EXHAUST SYSTEM FOR A VEHICULAR POSITIVE IGNITION INTERNAL COMBUSTION ENGINE - An exhaust system for a vehicular positive ignition internal combustion engine comprises a filter for filtering particulate matter from exhaust gas emitted from the engine, which filter comprising a porous substrate having inlet and outlet surfaces, wherein the inlet surfaces are separated from the outlet surfaces by a porous structure containing pores of a first mean pore size, wherein the porous substrate is coated with a three-way catalyst washcoat comprising a plurality of solid particles wherein the porous structure of the washcoated porous substrate contains pores of a second mean pore size, which is less than the first mean pore size, and a three-way catalyst washcoat disposed on a separate substrate monolith located upstream of the filter, wherein a mass of three-way catalyst washcoat on the upstream substrate monolith is ≦75% of the total mass of three-way catalyst washcoat in the exhaust system. | 2011-06-30 |
20110158872 | Method and System for Adsorbing Pollutants and/or Contaminants - The present invention relates to a method and a multi-component system for adsorbing contaminants and/or pollutants from a contaminated hot fluid by using a turbulent air stream, to adiabatically cool the temperature of the fluid, in association with one or more adsorbents. The system of the present invention can also be coupled to a recovery and recycling unit to recover and recycle the contaminant and/or pollutant and the adsorbent material. | 2011-06-30 |
20110158873 | SEQUESTRATION OF A GAS EMITTED BY AN INDUSTRIAL PLANT - A method of sequestering a multi-element gas emitted by an industrial plant is described herein, the method comprising: contacting a solution, including a first reactant comprising a multi-element gas emitted by an industrial plant and at least one gas absorber comprising nitrogen, for example ammonia or an amine, with a solid, including a second reactant, under conditions that promote a reaction between the first reactant and the second reactant to provide a first product, which incorporates one or more elements of the multi-element gas, thereby sequestering the multi-element gas. | 2011-06-30 |
20110158874 | Gas Separation Process - A process for the separation of carbon dioxide from gas mixtures is disclosed in which a metal oxide sorbent, which is used to capture and release carbon dioxide, is recycled. The process incorporates the regeneration of the carbon dioxide capture capacity of the metal oxide to maintain a high capture capacity over many cycles. The regeneration involves hydrating the metal oxide and then heating the resulting metal hydroxide under a gas atmosphere that is effective to suppress the dehydration of the hydroxide so that dehydration occurs at an elevated temperature. The regeneration may also be used independently from the carbon dioxide separation process to produce, from a metal hydroxide, a metal oxide having an enhanced resistance to attrition and fragmentation. | 2011-06-30 |
20110158875 | SELECTIVE CATALYTIC OXIDATION OF AMMONIA TO WATER AND NITROGEN - A catalyst includes a platinum coating deposited on a silica support. The support has an average surface area between about 100 m | 2011-06-30 |
20110158876 | INTEGRATED EXHAUST GAS COOLING SYSTEM AND METHOD - An integrated exhaust gas cooling system and method, including an expansion joint linking the system to an upstream source of exhaust gas and a pre-oxidation section through which exhaust gas travels. A hot temperature zone in which the exhaust gas is maintained at a temperature optimal for an oxidation process extends through the pre-oxidation section. An oxidation catalyst in the hot temperature zone is provided. The exhaust gas passes through the oxidation catalyst. Oxidized exhaust gas passes a post-oxidation section downstream of the oxidation catalyst. A tempering air stream is injected into the post-oxidation section to create a cool temperature zone in which the oxidized exhaust gas is cooled below the temperature in the hot temperature zone and to a temperature optimal for a reduction process. The system includes a reduction catalyst in the cool temperature zone through which the oxidized exhaust gas passes. | 2011-06-30 |
20110158877 | METHOD FOR THE DECOMPOSITION OF N2O, CATALYST FOR IT, AND THE PREPARATION OF THIS CATALYST - A method for the catalytic decomposition of N | 2011-06-30 |
20110158878 | METHOD AND DEVICE FOR PROCESSING EXHAUST GAS - An exhaust gas processing method of the present invention includes sequentially introducing an exhaust gas from a semiconductor manufacturing equipment to a combustion-based detoxifying device, a dust collector, and a two-stage gas cleaning device, so as to process the exhaust gas, wherein the two-stage gas cleaning device is comprised of a first-stage gas cleaning device and a second-stage gas cleaning device, and gas cleaning is performed in the first gas cleaning device that uses water as a cleaning solution and subsequently in the second gas cleaning device that uses an alkaline aqueous solution as a cleaning solution. | 2011-06-30 |
20110158879 | METHODS OF CONTROLLING HYDROGEN CONCENTRATIONS IN AN OFFGAS SYSTEM OF A NUCLEAR REACTOR BY PASSIVE AIR INJECTION - Example embodiments relate to methods of controlling hydrogen concentrations in an offgas system of a nuclear reactor by passive air injection. A method according to a non-limiting embodiment may include passively injecting ambient air through the hydrogen water chemistry system into an existing offgas line of the offgas system. The offgas line is configured to transport non-condensable gases, including hydrogen, from a condenser to a recombiner. As a result of the passive air injection, the combined flow of hydrogen and oxygen react in the recombiner to form water vapor, thereby reducing the hydrogen concentration of the offgas exiting the recombiner. | 2011-06-30 |
20110158880 | ANISOTROPIC CTE LSM FOR SOFC CATHODE - An anisotropic coefficient of thermal expansion (CTE) cathode of a solid oxide fuel cell (SOFC) is formed by placing a layer of perovskite powder between two platens, and sintering the layer while applying pressure to the platens, thereby forming the anisotropic CTE cathode. The perovskite can be lanthanum strontium manganite (LSM). | 2011-06-30 |
20110158881 | METHOD OF SYNTHESIZING CRYSTALLINE POLYMERIC BORON-NITROGEN COMPOUND AND DEHYDROGENATION OF BORON-NITROGEN-HYDROGEN COMPLEX - The present invention provides a method for synthesis of crystalline polymeric boron-nitrogen compounds comprising a step of dehydrogenation of a boron-nitrogen-hydrogen compound on catalyst, wherein the boron-nitrogen-hydrogen compound is selected from the group consisting of ammonia borane, metal amidoboranes, amine boranes or mixtures thereof, and the catalyst is selected from the group consisting of transition metals, transition metal salts or alloys. | 2011-06-30 |
20110158882 | Methods For Producing Silicon Tetrafluoride - Methods for producing silicon tetrafluoride by acid digestion of fluoride salts of alkali metal or alkaline earth metal and aluminum, optionally, in the presence of a source of silicon; methods for producing silane that include acid digestion of by-products of silane production to produce silicon tetrafluoride. | 2011-06-30 |
20110158883 | CATALYTIC HYDROGENATION - The invention relates to a method for the catalytic hydrogenation of halogenated silanes or halogenated germanes, according to which halogenated monosilanes, oligosilanes or polysilanes, or monogermanes, oligogermanes or polygermanes, are hydrogenated or partially hydrogenated with hydrogenated Lewis acid-base pairs, and the partially halogenated Lewis acid base pairs can be rehydrogenated, especially with further addition of H | 2011-06-30 |
20110158884 | Preparation Of Organohalosilanes and Halosilanes - A semi-continuous process for producing organohalosilanes or halosilanes in a fluidised bed reactor, from silicon-containing contact mass, comprising removing silicon-containing contact mass that has been used in said reactor by: (i) elutriation in an unreacted organohalide or hydrogen halide stream and/or an organohalosilane or halosilane product stream and (ii) direct removal using gravitational or pressure differential methods and returning removed silicon-containing contact mass to the fluidised bed reactor and/or fresh silicon-containing contact mass. When used for producing organohalosilanes (e.g. alkylhalosilanes) the silicon-containing contact mass may contain catalysts and promoters in addition to silicon. | 2011-06-30 |
20110158885 | HIGH PURITY CRYSTALLINE SILICON, HIGH PURITY SILICON TETRACHLORIDE AND PROCESSES FOR PRODUCING THE SAME - An object of the present invention is to provide more inexpensive high purity crystalline silicon which can satisfy not only a quality required to a raw material of silicon for a solar cell but also a part of a quality required to silicon for an up-to-date semiconductor and a production process for the same and provide high purity silicon tetrachloride used for production of high purity crystalline silicon and a production process for the same. The high purity crystalline silicon of the present invention has a boron content of 0.015 ppmw or less and a zinc content of 50 to 1000 ppbw. The production process for high purity crystalline silicon according to the present invention is characterized by that a silicon tetrachloride gas and a zinc gas are supplied to a vertical reactor to react them at 800 to 1200° C., whereby crude crystalline silicon is formed at a chip part of a silicon tetrachloride gas-supplying nozzle, and the crude crystalline silicon is grown downward from the chip part of the silicon tetrachloride gas-supplying nozzle; the grown crude crystalline silicon is discharged to an outside of the reactor, and the discharged crude crystalline silicon is subjected to acid treatment. | 2011-06-30 |
20110158886 | POLYSILANE PRODUCTION PROCESS - A polysilane production process comprising reacting a specific silane compound typified by a cyclic silane compound represented by the following formula (2) in the presence of a binuclear metal complex represented by the following formula (4). | 2011-06-30 |
20110158887 | Apparatus and method of use for casting system with independent melting and solidification - This invention relates to a two or three-stage apparatus and method of use to produce high purity silicon, such as for use in solar panels and/or photovoltaics. The device of this invention includes a melting apparatus with a delivery device, a holding apparatus with a tipping or transfer mechanism, and at least one solidification apparatus for receiving a molten feedstock. The optimized designs of individual apparatuses function efficiently in combination to produce high purity silicon. | 2011-06-30 |
20110158888 | METHODS FOR REDUCING THE DEPOSITION OF SILICON ON REACTOR WALLS USING PERIPHERAL SILICON TETRACHLORIDE - Fluidized bed reactor systems and distributors are disclosed as well as processes for producing polycrystalline silicon from a thermally decomposable silicon compound such as trichlorosilane. The processes generally involve reduction of silicon deposits on reactor walls during polycrystalline silicon production by use of a silicon tetrahalide. | 2011-06-30 |
20110158889 | SYSTEM AND METHOD FOR AMMONIA SYNTHESIS - Systems and methods are disclosed herein for synthesizing ammonia at mid- to low-pressures using nano-size metal or metal alloy catalyst particles. Hydrogen and nitrogen gases are passed through a system comprising, for example, a packed bed of supported nano-size iron or iron alloy catalyst particles having an optional oxide layer that form the catalyst. | 2011-06-30 |
20110158890 | PROCESS TO PREPARE PRECIPITATED CALCIUM CARBONATE IMPLEMENTING LOW CHARGE ACRYLATE A/O MALEINATE-CONTAINING POLYMER - Process to prepare a precipitated calcium carbonate (PCC) comprising the following steps: (i) providing CaO, which is optionally partially or fully slaked (hereafter “calcium source”); ({umlaut over (ν)}) providing a CO | 2011-06-30 |
20110158891 | CO2 RECOVERY SYSTEM AND CO2 RECOVERY METHOD - To further reduce the concentrations of basic amine compounds remaining in decarbonated flue gas. | 2011-06-30 |
20110158892 | PROCESS FOR PRODUCING CARBON NANOMATERIAL AND SYSTEM FOR PRODUCING CARBON NANOMATERIAL - A process for producing a carbon nanomaterial, including fluidizing a carbon raw material, a catalyst and a fluidizing material in a fluidized bed reactor to produce the carbon nanomaterial, wherein the fluidizing material is a carbon material. A carbon nanomaterial production system for producing a carbon nanomaterial including a fluidized bed reactor for fluidizing a car-bon raw material, a catalyst and a fluidizing material to carry out the reaction thereof, a carbon raw material feeding device for feeding the carbon raw material to the fluidized bed reactor, a catalyst feeding device for feeding the catalyst to the fluidized bed reactor, and a recovering device for recovering the produced carbon nanomaterial from the fluidized bed reactor, wherein a part of the recovered carbon nanomaterial is transferred to the catalyst feeding device and used as the fluidizing material. | 2011-06-30 |
20110158893 | PROCESS TO PRODUCE CARBON NANOTUBES FROM MICROALGAE - We disclose a process to produce carbon nanotubes from microalgae. Microalgae is been utilized for biodiesel production. The algal membrane resulted from oil extraction of microalgae is used here to produce carbon nanotubes. The process utilized for the conversion is composed of two steps, in the first step the algal membrane is converted to carbon black through a pyrolysis process in inert atmosphere, in the second step the resulted carbon black is converted to carbon nanotubes by mixing the carbon black with a fluid with known self ignition condition and subjecting the mix to said self ignition condition. | 2011-06-30 |
20110158894 | METHOD AND DEVICE FOR CNT LENGTH CONTROL - A method for manufacturing a carbon nanotube (CNT) of a predetermined length is disclosed. The method includes generating an electric field to align one or more CNTs and severing the one or more aligned CNTs at a predetermined location. The severing each of the aligned CNTs may include etching the predetermined location of the one or more aligned CNTs and applying a voltage across the one or more etched CNTs. | 2011-06-30 |
20110158895 | HIGH MODULE CARBON FIBER AND METHOD FOR FABRICATING THE SAME - The invention provides a high module carbon fiber and a fabrication method thereof. The high module carbon fiber includes the product fabricated by the following steps: subjecting a pre-oxidized carbon fiber to a microwave assisted graphitization process, wherein the pre-oxidized carbon fiber is heated to a graphitization temperature of 1000-3000° C. for 1-30 min. Further, the high module carbon fiber has a tensile strength of between 2.0-6.5 GPa and a module of between 200-650 GPa. | 2011-06-30 |
20110158896 | Methods For Producing Aluminum Trifluoride - Methods for producing aluminum trifluoride by acid digestion of fluoride salts of alkali metal or alkaline earth metal and aluminum, optionally, in the presence of a source of silicon; methods for producing silane that include acid digestion of by-products of silane production to produce aluminum trifluoride. | 2011-06-30 |
20110158897 | PROCESS FOR PRODUCING CHLORINE - There is disclosed a process for producing chlorine by feeding hydrogen chloride and oxygen into catalyst beds which are formed in the reaction tubes of a fixed-bed multitubular reactor and which contain catalysts for use in oxidation of hydrochloric acid, and this process is characterized in that
| 2011-06-30 |
20110158898 | Method for manufacturing potassium titanate - A potassium titanate, method for manufacturing the potassium titanate, a friction material using the potassium titanate and a resin composition using the potassium titanate are disclosed. The potassium titanate is represented by K | 2011-06-30 |
20110158899 | METHOD FOR PRODUCING HYDROGEN - An object of the present invention is to provide a method for producing hydrogen by using formic acid as a feedstock, which provides a solution to problems to be solved for the production of hydrogen on an industrial scale, such as problems of production cost, storability and transportability, and also offers improved convenience. The method for producing hydrogen of the present invention is characterized by heating an ionic liquid containing formic acid. The ionic liquid is preferably an ionic liquid in which a counteranion is a formate anion (i.e., formic acid salt). Such an ionic liquid is, as a medium for the production of hydrogen from formic acid as a feedstock, excellent in terms of reaction selectivity (high-purity hydrogen is produced) and reaction velocity. | 2011-06-30 |
20110158900 | Reduction of greenhouse gas emission from petroleum refineries - The invention described herein relates to a novel process that eliminates the need for post combustion CO | 2011-06-30 |
20110158901 | CHITOSAN-BASED NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME - Water-dispersible chitosan-based nanoparticles comprising a cross-linked chitosan polymer are provided. The chitosan-based nanoparticles advantageously have a particle size of about 100 nm or less and may include an imaging agent, a target-specific ligand, and/or a biologically active compound bonded to the chitosan polymer. | 2011-06-30 |
20110158902 | RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS - The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences. | 2011-06-30 |
20110158903 | ONE POT PROCESSES OF PREPARING MULTIFUNCTIONAL LIPOSOME DRUG FOR IMAGING, DELIVERY AND TARGETING IN CANCER DIAGNOSIS AND THERAPY - One pot process of preparing multifunctional liposome drug is provided. In this one pot process, liposome reacted with radionuclide labeled solution, chemotherapy drug, and targeted ligand at appropriate temperature. The product in this invention for preparation multifunctional liposome drugs in for imaging, delivery and targeting in cancer diagnosis and therapy has proved to be more simple, convenient, effective and easier than the prior art is. | 2011-06-30 |
20110158904 | ANTIBODIES THAT BIND CELL-ASSOCIATED CA 125/O772P AND METHODS OF USE THEREOF - The present invention provides antibodies, and antigen-binding fragments of antibodies, fusion polypeptides and analogs that preferentially bind cell-associated CA 125/O772P polypeptides relative to shed CA 125/O772P polypeptides. The present invention further provides methods of preventing, managing, treating or ameliorating one or more symptoms associated with a CA 125/O772P-related disorder. In particular, the present invention provides methods of preventing, managing, treating, or ameliorating one or more symptoms associated with a cell proliferative disorder, such as cancer, e.g., ovarian cancer. The present invention still further provides methods for diagnosing a CA 125/O772P-related disorder or predisposition to developing such a disorder, as well as methods for identifying antibodies, and antigen-binding fragments of antibodies, that preferentially bind cell-associated CA 125/O772P polypeptides relative to shed CA 125/O772P polypeptides. | 2011-06-30 |
20110158905 | Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use - Disclosed herein are methods and compositions dock and lock (DNL) complexes comprising an AD moiety selected from an AKAP protein and a DDD moiety selected from a protein kinase A regulatory subunit. Also disclosed are fusion proteins comprising an AD moiety or DDD moiety attached to an effector moiety. The DDD moieties form dimers that bind to the AD moiety to form the DNL complexes. The effector moieties may be selected from a wide range of known effector moieties that produce one or more physiological effects, including but not limited to cell death. The DNL complexes may further comprise one or more diagnostic and/or therapeutic agents. The DNL complexes are of use for treating and/or diagnosing a variety of diseases or conditions. | 2011-06-30 |
20110158906 | TARGETED BLOCK COPOLYMER MICELLES - The present invention provides a micelle comprising an amphiphilic block copolymer, said amphiphilic block copolymer consisting of (a) a hydrophobic polymer attached to the 5′ end of a first nucleic acid molecule, wherein said first nucleic acid molecule is hybridized with a second nucleic acid molecule, wherein a targeting unit capable of selectively binding to a specific cell type and/or tissue is attached to the 5′ end of said second nucleic acid molecule; and/or (b) a hydrophobic polymer attached to the 3′ end of a first nucleic acid molecule, wherein said first nucleic acid molecule is hybridized with a second nucleic acid molecule, wherein a targeting unit capable of selectively binding to a specific cell type and/or tissue is attached to the 3′ end of said second nucleic acid molecule. | 2011-06-30 |
20110158907 | DIPHENYL-HETEROARYL DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES - This invention relates to a method of imaging amyloid deposits and to diphenyl-heteroaryl compounds, and methods of making radiolabeled diphenyl-heteroaryl compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits. | 2011-06-30 |
20110158908 | CYCLOSPORIN A-BINDING PROTEIN - Disclosed are: a composition and a method for the diagnosis and/or the treatment of a CSABP-related disease, the regulation of the proliferation of an RNA virus and the regulation of an RNA-metabolizing system, which targets a cyclosporin A-binding protein (CSABP); a method for the screening of a component that targets a CSABP; a composition and a method for the detection/inhibition of CsA, NS5B or cyclosphilin B by utilizing a CSABP; a promoter for a CSABP; a method for the screening of a substance capable of regulating the expression of a CSABP by utilizing the promoter; and a method for the determination of the occurrence or clinical stage of a CSABP-related disease. | 2011-06-30 |
20110158909 | Cationic Contrast Agents and Methods of Use Thereof - The present invention provides compounds useful as contrast agents, such as for the CT imaging of cartilage tissue. The contrast agents are generally iodinated organic molecules that are positively charged under physiological environments. Also provided are compositions containing contrast agents and methods of using the agents, including, for example, the monitoring of glycosaminoglycan content in cartilage tissue. The invention provides non-invasive analytical techniques for the diagnosis of osteoarthritis in its earliest stages. The invention also provides improvements over existing contrast agents for cartilage monitoring, which tend to exhibit low residence times and require high dosages. | 2011-06-30 |
20110158910 | MICROPARTICLES COMPRISING POLYMERS WITH THIOESTER BONDS - The present invention relates to particles suitable for delivery of active agents comprising a polymer containing thioester bonds which are obtained via the reaction of a thioic acid functionality and an unsaturated group. The polymer may be is linear, branched or crosslinked. The particles have an average diameter in the range of 10 nm to 1000 μm, preferably in the range of 100 nm-100 μm. The particles may comprise an active agent selected from the group of nutrients, pharmaceuticals, proteins and peptides, vaccines, genetic materials, diagnostic agents or imaging agents. The present invention further relates to the use of the particles in dermatology, muscular skeletal, oncology, in vascular applications, in orthopaedics, in ophthamology, spinal, intestinal, pulmonary, nasal, or auricular. | 2011-06-30 |
20110158911 | Methods for Screening for Antibiotic Compounds - The present invention is a method for screening drugs for antibiotic activity by screening a drug for activity to disrupt a toxin-antitoxin complex in a bacterial cell. | 2011-06-30 |
20110158912 | METHOD AND DEVICE FOR DETERMINING THE SEVERITY OF A PAIN DISORDER - A method for determining the severity of a pain disorder in a subject, comprising the steps of: (i) topically applying an effective amount of menthol or a functional equivalent thereof to the subject's painful area and other locations; and (ii) measuring the response of the subject | 2011-06-30 |
20110158913 | Antisense and pretargeting optical imaging - The present invention relates, in part, to detectably labeled oligomer duplexes and their use in optical imaging, including, in vivo optical imaging. The invention includes methods of optical imaging including in vivo pretargeting methods and in vivo antisense optical imaging methods. | 2011-06-30 |
20110158914 | FLUORESCENCE IMAGE CAPTURING METHOD AND APPARATUS - A fluorescence image capturing apparatus for capturing a fluorescence image by receiving fluorescence emitted from an observation area administered with a fluorescent agent, in which pharmacokinetic information of the fluorescent agent is obtained and the intensity of the excitation light and/or the charge storage period of the image sensor is controlled based on the pharmacokinetic information of the fluorescent agent. | 2011-06-30 |
20110158915 | NANOSHELLS WITH TARGETED ENHANCEMENT OF MAGNETIC AND OPTICAL IMAGING AND PHOTOTHERMAL THERAPEUTIC RESPONSE - A particle and a method of manufacturing a particle that includes a complex, a paramagnetic entity, and a silica layer that encapsulates the paramagnetic entity and the complex. The dielectric layer of the particle encapsulates the complex and the paramagnetic entity such that at least a portion of an outer surface of the complex is covered by the paramagnetic entity. In addition, the particle may or may not include a fluorescent entity encapsulated within the dielectric layer. Also, the particle may or may not include a targeting entity covalently bonded to the silica layer. | 2011-06-30 |
20110158916 | Anti-viral tissue product with visual indicator - Anti-viral tissues are provided with a pH indicator which provides the tissue user with a visual indicia, via color changes, that the tissue has active ingredients. Furthermore, the pH indicators can be used to illustrate neutralization of the pH of infected nasal discharge, which has a higher pH than healthy nasal discharge, giving the user a reason to believe that the product is working to deactivate virus. | 2011-06-30 |
20110158917 | ANTI-VIRAL TISSUE PRODUCT WITH VISUAL EFFICACY INDICATOR - Anti-viral tissues are provided with a pH indicator which can communicate to a tissue user by means of visual indicia, via color changes, that the tissue has active ingredients. Furthermore, the pH indicators can be used to illustrate neutralization of the pH of infected nasal discharge, which has a higher pH than healthy nasal discharge, giving the user a reason to believe that the product is working to deactivate virus. | 2011-06-30 |
20110158918 | ORAL CAVITY STIMULATING SUBSTANCE - A novel compound causing an oral cavity stimulus such as acridness, which is expressed by the following structural formula (I): | 2011-06-30 |
20110158919 | AROMA COMPOSITION COMPRISING O-COUMARIC ACID TO REDUCE OR SUPPRESS UNDESIRABLE TASTE IMPRESSIONS OF SWEETENERS - The invention concerns an aroma composition to reduce or suppress undesirable taste impressions, in particular a bitter, astringent and/or sweetener-like taste and/or long-lasting aftertaste of a sweetener, in the oral cavity, comprising (i) one or more sweeteners and (ii) ortho-coumaric acid (OCA) and optionally (iii) one or more specific bitter-masking aroma substances and/or flavourings and optionally (iv) one or more sweetness intensifying aroma substances and/or sweeteners and optionally (v) one or more inactive substances or carriers. The invention also concerns a preparation, containing such an aroma composition. The invention also relates to the use of ortho-coumaric acid or of certrain aroma compositions comprising ortho-coumaric acid for reducing or eliminating undesirable taste effects, in particular a bitter, astringent and/or sweetener-like taste and/or long-lasting aftertaste of a sweetener, and corresponding methods for reducing or eliminating the undesirable taste impression, in particular a bitter, astringent and/or sweetener-like taste and/or long-lasting aftertaste of a sweetener. | 2011-06-30 |
20110158920 | METHOD OF PRODUCING A COMPOSITION FROM AN OLEOGEL AND AN AQUEOUS GEL AND THE COMPOSITION - A method for producing a bigel, the method comprising: (a) providing an oleogel comprising at least one oily agent gelled with at least one cellulose polymer; (b) providing an aqueous gel comprising at least one component whose viscosity is pH dependent, such as a carbomer; (c) mixing the oleogel and the aqueous gel together to form a bigel; and (d) subsequently adjusting the viscosity of the bigel under high flow and low shear stirring to obtain a bigel of a desired viscosity. | 2011-06-30 |
20110158921 | Methods of blocking ultraviolet radiation and promoting skin growth using terpenes and terpenoids - The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by ultraviolet radiation (UVR). More specifically it provides terpenes and terpenoids as ingredients that work as persistent UVR blockers. Terpenes and terpenoid compounds support the growth of skin, skin tissue and keratinocytes and additional UVR-blocking by reason of increased stratum corneum thickness and loricrin content. Both terpenes and terpenoids may be applied topically or orally at oral or topical concentrations from about 6 mg to about 600 mg per kilogram of body weight per day effective to stimulate growth of the skin layer and prevent damage from ultraviolet radiation (UVR). | 2011-06-30 |
20110158922 | Skin Care Compositions and Method of Use Thereof - A topical composition comprising at least 10 isolated active agents which each have at least one activity selected from the group consisting of anti-oxidant activity, anti-matrix metalloproteinase (MPP) activity, anti-elastase activity, anti-inflammation activity, anti-irritation activity, microcirculation support activity, collagen synthesis activity, energy production activity, oxygenation activity, DNA protection and repair activity, cell anchorage support activity, dermal-epidermal cohesion support activity, cellular renewal activity, synthesis and/or protection of glycosaminoglycans activity, prevention and/or repair and/or elimination of damaged proteins activity, protection of skin immune function activity, hydration activity, modulation of skin pigmentation activity, and anti-cellulite activity, the composition possessing at least five of the foregoing activitie. Methods of use thereof. | 2011-06-30 |
20110158923 | Suspensions of Silicate Shell Microcapsules - Aqueous suspensions of silicate shell microcapsules having a volume fraction of microcapsules of at least 30% that are gel free at 50° C. for at least one month and processes for obtaining them are disclosed. A process for improving the stability of an aqueous suspension of silicate shell microcapsules is disclosed which involves reducing non-volatile solid content of the continuous phase of the aqueous suspension of the silicate shell microcapsules to less than 0.3 weight percent. A process is also disclosed for improving the stability of an aqueous suspension of silicate shell microcapsules by adding a colloidal silicate sequestering agent to an aqueous suspension of silicate shell microcapsules and colloidal silicate particles. | 2011-06-30 |
20110158924 | PHOTO-PROTECTIVE DERMATOLOGICAL FORMULATIONS - A dermatological formulation is disclosed comprising one or more amino acid-based antioxidants in an amount effective to reduce photodamage to skin exposed to UV radiation, and a dermatologically acceptable carrier, wherein the amino acid-based antioxidant includes an amino acid selected from the group consisting of proline, cysteine, tryptophan, threonine, histidine, serine, methionine, lysine and phenylalanine. | 2011-06-30 |
20110158925 | DYEING OR LIGHTENING COMPOSITIONS COMPRISING AT LEAST ONE FATTY SUBSTANCE AND AT LEAST ONE AMPHOTERIC POLYMER - The subject of the present disclosure relates to compositions for dyeing or lightening human keratin fibers, comprising: (a) at least 25% by weight of at least one fatty substance; (b) at least one amphoteric polymer; (c) at least one basifying agent; and (d) at least one oxidizing agent. The present disclosure also relates to a dyeing or lightening processes using the composition, and two- and three-compartment devices which make it possible to obtain a composition according to the present disclosure, after mixing of the compositions of the compartments just before application of the composition according to the present disclosure. | 2011-06-30 |
20110158926 | Use of a cruciferous protein hydrolysate as a depigmentation agent or for a cosmetic and/or pharmaceutical composition - The use of an effective quantity of a protein hydrolysate from plants belonging to the crucifer family, as whitening and/or depigmenting skin agent, for the preparation of a cosmetic and/or dermatological and/or pharmaceutical composition. In a preferred embodiment, the hydrolysate is obtained from rapeseed proteins. Also the composition may contain the aforementioned hydrolysate in a cosmetically and/or pharmaceutically acceptable excipient chosen between glycerol, propanediol and butylene glycol. | 2011-06-30 |
20110158927 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ORGANOSILICON COMPOUND, AT LEAST ONE ANIONIC SURFACTANT AND AT LEAST ONE CATIONIC POLYMER - The present disclosure relates to a cosmetic composition for washing and conditioning keratin fibers, including human keratin fibers such as the hair, comprising, in a cosmetically acceptable medium: (i) at least one organosilicon compound chosen from silanes comprising one silicon atom and siloxanes comprising two or three silicon atoms, the organosilicon compounds also comprising at least one basic chemical functional group and at least one group chosen from hydroxyl and hydrolyzable groups per molecule; (ii) at least one anionic surfactant; and (iii) at least one cationic polymer. | 2011-06-30 |
20110158928 | AGENT FOR FIBRES CONTAINING KERATIN, CONTAINING AT LEAST ONE SPECIFIC AMPHIPHILIC CATIONIC POLYMER AND AT LEAST ONE SPECIFIC, ADDITIONAL FILM-FORMING NON-IONIC AND/OR STABILIZING NON-IONIC POLYMER - Agent for treating fibres containing keratin, in particular human hair, comprising, in a cosmetically acceptable carrier: (a) at least one amphiphilic, cationic polymer having at least one structural unit of formulae (I) to (IV), wherein R | 2011-06-30 |
20110158929 | METHOD FOR PRODUCING CROSS-LINKED ACRYLIC ACID POLYMERS - The present invention relates to a method of producing crosslinked acrylic acid polymers, wherein the method is a precipitation polymerization which is carried out in a solvent comprising hydrocarbon and/or alkyl ester at least two different temperatures and with at least two different initiators. The present invention further relates to crosslinked polymers which are obtainable by the method according to the invention, and also to cosmetic and pharmaceutical preparations which comprise such polymers. | 2011-06-30 |
20110158930 | METHOD FOR TREATMENT OF IRRITABLE BOWEL SYNDROME - A method for treatment of a patient suffering from irritable bowel syndrome with diarrhea or mixed irritable bowel syndrome, which comprises administering to the patient a therapeutically effective amount of ramosetron or a pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of polycarbophil or a pharmaceutically acceptable salt thereof. | 2011-06-30 |
20110158931 | Rotor-stator system for the production of dispersions - A rotor-stator system with which stable dispersions can be produced in one single cycle and can be flexibly adjusted to changing requirements to the composition of the dispersion. A stator for a rotor-stator system provided with a dispersion zone, wherein a rotor corresponding with the stator defines a dispersion chamber, and with an inlet for feeding a first component of a dispersion into the dispersion zone, the inside of the stator accommodating a premixing chamber outside the dispersion zone, said premixing chamber opening into the dispersion zone, and the stator having an intake for feeding an additional component of the dispersion from outside the stator into the premixing chamber, and during operation of the stator, components of the dispersion enter the premixing chamber from the dispersion zone and from the intake, are mixed in said premixing chamber and exit from said premixing chamber into the dispersion zone. | 2011-06-30 |
20110158932 | Methods And Compositions For The Treatment of Hyperlipidemia - Methods and compositions containing a berberine compound or berberine related or derivative compound are provided for the prevention and treatment of hyperlipidemia, elevated cholesterol, and/or cardiovascular disease in mammalian subjects. The methods and compositions of the invention are effective for prevention and treatment of atherosclerosis, coronary artery disease, angina pectoris, carotid artery disease, stroke, cerebral arteriosclerosis, high blood pressure, myocardial infarction, cerebral infarction, restenosis following balloon angioplasty, intermittent claudication, dyslipidemia post-prandial lipidemia or xanthoma. Additional compositions and methods are provided which employ a berberine compound or berberine related or derivative compound in combination with a second anti-hyperlipidemia agent, or a different therapeutic agent to yield more effective treatment tools against hyperlipidemia and/or cardiovascular disease, and/or dual activity therapeutic methods and formulations useful to prevent or reduce hyperlipidemia and one or more causal or related symptoms or conditions associated with hyperlipidemia in mammalian subjects. | 2011-06-30 |
20110158933 | LIVER FUNCTION AND TREATMENT OF LIVER DISEASE - A pharmaceutical preparation containing polymeric compounds as shown in the specification. This preparation can be used to improve liver function and treat liver disease, and promoting liver tissue regeneration. | 2011-06-30 |
20110158934 | FLY ATTRACTANT COMPOSITION AND FLY ATTRACTING METHOD, AS WELL AS FLY EXPELLANT COMPOSITION AND FLY EXPELLING METHOD - Provided are a fly attractant composition containing a ligninsulfonate as an active ingredient, and a fly expellant composition containing 5 to 20% by weight of a ligninsulfonate and at least 0.1% by weight but less than 5% by weight of an insecticidal active ingredient. | 2011-06-30 |
20110158935 | Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents - Disclosed are drug delivery systems for the delivery of small molecule and macromolecular drugs. More particularly, disclosed are substituted analogs of 3,6-di(alkyl-4 aminobutyl)-2,5-diketopiperazine (which may also be referred to DKP), their use in the formulation of both small molecule and macromolecular drugs including therapeutic, prophylactic and diagnostic agents, stabilizing agents and systems for their delivery. | 2011-06-30 |
20110158936 | USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER - The use of interleukin 17E to inhibit tumour growth in a subject is provided. The interleukin 17E can be provided to the subject exogenously, as an interleukin 17E polypeptide or a polynucleotide encoding an interleukin 17E polypeptide, or it can be provided by stimulating production of endogenous interleukin 17E. Also provided is the use of interleukin 17E in combination with one or more anti-cancer therapeutics for inhibiting tumour growth in a subject. Anti-cancer therapeutics include, for example, standard chemotherapeutic drugs, immunotherapeutics, radiation, gene therapy, hormone manipulation and antisense therapy. | 2011-06-30 |
20110158937 | SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY - The invention provides optimized methods and compositions for enhancing the immune response caused by immunostimulatory compounds used for the treatment of disease such as, but not limited to, treatment of cancer, autoimmune disorders, asthma, respiratory allergies, food allergies and infectious diseases in a patient. The optimized methods according to the invention provide synergy between the therapeutic effects of immunostimulatory oligonucleotides and immunomer compounds in accordance with the invention, and the therapeutic effect of cytokine immunotherapy and/or chemotherapeutic agents and/or radiation. | 2011-06-30 |
20110158938 | IL-15 BINDING SITE FOR IL 15-RALPHA AND SPECIFIC IL-15 MUTANTS HAVING AGONISTS / ANTAGONISTS ACTIVITY - The present invention relates to the identification of an epitope in human Interleukin-15 (IL-15) that is responsible for binding to the interleukin-15 receptor α-chain. Two IL-15 regions are involved in the formation of this epitope: the first region ( | 2011-06-30 |
20110158939 | Methods and Compositions for Treating Asthma in Human and Nonhuman Primates - The present invention relates generally to methods and compounds for treating pulmonary disorders, and more specifically to the inhalation administration and use of hIL-4 mutant proteins to treat asthma. | 2011-06-30 |
20110158940 | SAMLL MOLECULE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DENGUE VIRUS INFECTION - Methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. | 2011-06-30 |
20110158941 | CRYSTALLINE RECOMBINANT INTERFERON WITH ALTERED SPATIAL CONFIGURATION, THREE-DIMENSIONAL STRUCTURE AND USES THEREOF - This invention provides a crystalline recombinant interferon (rSIFN-co) having (i) the same amino acid sequence as that of human consensus interferon, and (ii) altered three-dimensional structure as compared to IFN-α2b. The interferon of the present invention exhibits enhanced biological activities. The present invention also provides a structure model of said interferon useful for drug screening and/or drug design and the mimetic of said interferon. | 2011-06-30 |
20110158942 | DIARYL UREAS FOR TREATING VIRUS INFECTIONS - The present invention relates to pharmaceutical compositions for treating virus infections and/or diseases caused by virus infections comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound. | 2011-06-30 |
20110158943 | INTERFERON ALPHA 2B MODIFIED BY POLYETHYLENE GLYCOL, THE PREPARATION AND USE THEREOF - The present invention relates to interferon-α2b modified with Y-shaped branched polyethylene glycol (PEG) at a single Lys residue and the preparation thereof. The peglated IFN-α2b can be used for the preparation of a medicament for treating a disease, e.g. viral infections such as Hepatitis C. | 2011-06-30 |
20110158944 | BRAF BIOMARKERS - The present invention provides, inter alia, methods for predicting the sensitivity of a disease, such as cancer, to an ERK1 or ERK2 or MEK inhibitor by detecting the presence of an allele of BRAF in cells mediating the disease. Methods of treatment are also provided. | 2011-06-30 |
20110158945 | MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT - Myxoma viruses that are deficient in the activity of a Myxoma virus protein selected from the group consisting of M11L, M063, M 136, M-T4 and M-T7 are useful for treating cancer. | 2011-06-30 |
20110158946 | Methods and Compositions for control of disease in aquaculture - The invention discloses paratransgenesis methods for prevention, amelioration and/or treatment of a disease or disorder in an aquatic animal. The method comprises providing a genetically modified micro algae that expresses a recombinant molecule that specifically targets one or more key epitopes of a pathogen that infects the aquatic animal and ii) feeding the aquatic animal directly or indirectly with the genetically modified unicellular algae. | 2011-06-30 |
20110158947 | SULFONYLUREA RECEPTOR AND MEANS FOR TREATING ISCHAEMIA - We disclose agents useful in the treatment of diseases or conditions that would benefit from improved muscle function and including pharmaceutical compositions and diagnostic tests for determining the predisposition of a subject, in particular a male subject, to cardiovascular disease. | 2011-06-30 |
20110158948 | Treatment Using Herpes Simplex Virus - Herpes Simplex Viruses are disclosed having single-chain antibodies (scFv) embedded in the viral envelope via fusion with glycoprotein D and with glycoprotein H and L. | 2011-06-30 |
20110158949 | Metabolically active micro organisms and methods for their production - The invention relates to a preparation of metabolically active bacteria, compositions comprising such a preparation, e.g., probiotic supplements or animal feeds, and to uses thereof, for example in the treatment of diseases affecting the intestinal microbial balance. Also described are a growth substrate for microorganisms comprising a mixture of complex and simple sugars and a process for the manufacture of preparations of metabolically active microorganisms using this growth substrate. | 2011-06-30 |
20110158950 | USE OF BLOOD GROUP STATUS I - Provided is a probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with non-secretor blood group phenotype. Further provided is a method of tailoring a probiotic composition based on the bifidobacteria found from the intestine of at least one non-secretor individual. | 2011-06-30 |
20110158951 | USE OF BLOOD GROUP STATUS II - Provided is a microbial or probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals of non-secretor blood group phenotype. Further provided is a method of tailoring a microbial or probiotic composition based on the bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals non-secretor blood group phenotype. | 2011-06-30 |